Stories Tagged: SNO 2023

🤷🤷🤷
Enterome to Present Updated Data From Phase 1/2 ROSALIE Trial of EO2401 in Recurrent Glioblastoma at SNO 2023

Enterome, a clinical-stage biopharmaceutical company, will present updated efficacy data from... (6 revisions)